Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01100528
Brief Title: Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

First Submitted : April 7, 2010
First Submitted that Met QC Criteria : April 7, 2010
First Posted : April 9, 2010 (Estimate)

Results First Submitted : September 25, 2018
Results First Submitted that Met QC Criteria : September 25, 2018
Results First Posted : October 29, 2018

Last Update Submitted that Met QC Criteria : February 11, 2019
Last Update Posted : February 26, 2019